You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

106 Results
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    anastrozole
Apr 2024
Regimen
Intent: Neoadjuvant, Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Feb 2022
Regimen
Intent: Neoadjuvant, Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Feb 2022
Drug
Other Name(s): Tecentriq™
Mar 2024
Drug
Other Name(s): Tecentriq® SC
Updated
May 2025
Drug
Other Name(s): Bavencio™
Jan 2025
Drug
Other Name(s): Calquence®
Jul 2024
Drug
Other Name(s): Vidaza®
Aug 2023
Drug
Other Name(s): Onureg®
Aug 2023
Drug
Other Name(s): Verzenio®
Feb 2025
Drug
Other Name(s): Alecensaro®
Apr 2024
Drug
Other Name(s): Proleukin® (interleukin-2)
Apr 2024

Pages